GUIDELINES FOR THE RATIONAL USE OF BRONCHODILATORS IN CHILDREN UNDER 3 YEARS OF AGE
Keywords:
Bronchodilators, pediatric asthma, wheezing, infants, beta-agonists, anticholinergics, nebulization, evidence-based pediatrics.Abstract
This article presents a critical overview of the rational use of
bronchodilators in children under three years of age. It addresses the pharmacological basis,
clinical indications, administration methods, and safety considerations specific to this
vulnerable age group. Drawing on international pediatric guidelines, the paper emphasizes
evidence-based prescribing, individualized risk-benefit assessment, and the need to avoid
overtreatment in cases of nonspecific wheezing. The aim is to provide a structured
framework for optimizing respiratory care while minimizing adverse outcomes.
References
American Academy of Pediatrics. Diagnosis and Management of Bronchiolitis. –
Pediatrics. – 2014. – Vol. 134, №5. – P. e1474–e1502.
Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and
Prevention – Updated 2023. – [Online resource]. – URL: https://ginasthma.org
Everard, M. L., Milner, A. D. The Use of Beta-Agonists in Preschool Children. – Pediatr
Pulmonol. – 2006. – Vol. 41, №11. – P. 1053–1062.
Gadomski, A. M., Scribani, M. Evidence-Based Review of the Effectiveness of
Bronchodilators for Bronchiolitis. – Pediatrics. – 2014. – Vol. 131, №4. – P. 585–595.
Turner, S. The use of inhaled bronchodilators in infants: What is the evidence? – Paediatr
Respir Rev. – 2015. – Vol. 16, №2. – P. 92–98.
